Related Experiment Video

Updated: Jun 23, 2026

Cell-free Biochemical Fluorometric Enzymatic Assay for High-throughput Measurement of Lipid Peroxidation in High Density Lipoprotein
07:29

Cell-free Biochemical Fluorometric Enzymatic Assay for High-throughput Measurement of Lipid Peroxidation in High Density Lipoprotein

Published on: October 12, 2017

Do DNA sequence variants in ABCA1 contribute to HDL cholesterol levels in the general population?

Päivi Pajukanta1

  • 1Department of Human Genetics, David Geffen School of Medicine at UCLA, University of California, Los Angeles, Los Angeles, California 90095-7088, USA. ppajukanta@mednet.ucla.edu

The Journal of Clinical Investigation
|November 3, 2004
PubMed

Insights

Genetic variations in the ABCA1 gene influence HDL cholesterol levels. This study provides evidence that ABCA1 sequence variants contribute to variations in plasma HDL cholesterol in the general population.

Area of Science:

  • Biochemistry
  • Genetics
  • Cardiovascular Science

Background:

  • High-density lipoprotein (HDL) is crucial for reverse cholesterol transport, moving cholesterol from tissues to the liver.
  • The ATP-binding cassette transporter A1 (ABCA1) protein facilitates cholesterol efflux to apolipoprotein AI (apoAI), the primary HDL component.
  • Mutations in ABCA1 cause Tangier disease, a rare condition characterized by severe HDL deficiency.

Purpose of the Study:

  • To investigate the role of ABCA1 sequence variants in plasma HDL cholesterol levels within the general population.
  • To provide genetic evidence supporting the hypothesis that ABCA1 variations impact HDL cholesterol homeostasis.

Main Methods:

  • Genetic analysis of ABCA1 sequence variants.
  • Correlation studies between ABCA1 variants and plasma HDL cholesterol levels.

Main Results:

  • The study identified specific ABCA1 sequence variants.
  • A significant association was found between certain ABCA1 variants and altered plasma HDL cholesterol levels.

Conclusions:

  • Sequence variants in the ABCA1 gene contribute to the variation in plasma HDL cholesterol levels observed in the general population.
  • These findings highlight the importance of ABCA1 in regulating HDL cholesterol homeostasis beyond its role in rare diseases.

More Related Videos

Application of DNA Fingerprinting using the D1S80 Locus in Lab Classes08:35

Application of DNA Fingerprinting using the D1S80 Locus in Lab Classes

Published on: July 17, 2021

High-Density Lipoprotein-Specific Phospholipid Efflux Assay07:08

High-Density Lipoprotein-Specific Phospholipid Efflux Assay

Published on: September 30, 2025

Related Concept Videos

Comparing Copy Number Variations and SNPs02:26

Comparing Copy Number Variations and SNPs

Sequencing of the human genome has opened up several best-kept secrets of the genome. Scientists have identified thousands of genome variations that exist within a population. These variations can be a single nucleotide or a larger chromosomal variation.
Copy number variations or CNVs are the structural variations that cover more than 1kb of DNA sequence. The single nucleotide polymorphism (SNP), on the other hand, is a single nucleotide change or a point mutation that is found in more than 1%...
Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
Cholesterol: Significance and Regulation01:29

Cholesterol: Significance and Regulation

Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu01:29

Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu

Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
Pharmacogenetics of Drug Transporters: P-Glycoprotein and Solute Carrier Transporters01:16

Pharmacogenetics of Drug Transporters: P-Glycoprotein and Solute Carrier Transporters

The pharmacogenetics of drug transporters is increasingly recognized as a critical factor influencing interindividual variability in drug absorption, distribution, and elimination. These membrane-bound proteins regulate drugs' movement across cellular barriers by actively pumping them out (efflux) or facilitating their uptake (influx). Among the major transporter families, ATP-binding cassette (ABC) and solute carrier (SLC) transporters play particularly prominent roles. Genetic polymorphisms...
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...